Artesunate Anti-Malarial Outcomes Confirmatory Trial Advised By Cmte.
Executive Summary
The World Health Organization should conduct a trial of artesunate rectal capsules looking at 28-day clinical outcomes to confirm efficacy of the antimalarial product, FDA's Anti-Infective Drugs Advisory Committee said July 10